# PSIL holdings: all 27 positions

> All 27 PSIL holdings with weights, as of Jun 30, 2026. The top 3 are DFTX 12.85%, CMPS 11.45% and ATAI 10.47%. Download the full list as a CSV.

Data as of Jun 30, 2026. Rebuilt every trading night.

PSIL held 27 positions as of Jun 30, 2026. Definium Therapeutics Inc is the largest at 12.85%; the top 10 are 69.2% of the fund.

Source: Form N-PORT filed with the SEC (https://www.sec.gov/Archives/edgar/data/1408970/000094040026033028/primary_doc.xml).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Definium Therapeutics Inc | DFTX | 12.85% |
| 2 | Compass Pathways PLC | CMPS | 11.45% |
| 3 | AtaiBeckley Inc | ATAI | 10.47% |
| 4 | Relmada Therapeutics Inc | RLMD | 6.84% |
| 5 | NRX Pharmaceuticals Inc | NRXP | 6.07% |
| 6 | Neurocrine Biosciences Inc | NBIX | 4.38% |
| 7 | Cybin Inc | HELP | 4.36% |
| 8 | GH Research PLC | GHRS | 4.31% |
| 9 | Alkermes PLC | ALKS | 4.30% |
| 10 | Alto Neuroscience Inc | ANRO | 4.20% |
| 11 | AbbVie Inc | ABBV | 4.14% |
| 12 | Bright Minds Biosciences Inc | DRUG | 3.83% |
| 13 | Johnson & Johnson | JNJ | 3.61% |
| 14 | Supernus Pharmaceuticals Inc | SUPN | 2.89% |
| 15 | Neuphoria Therapeutics Inc | NEUP | 2.49% |
| 16 | Neuronetics Inc | STIM | 2.17% |
| 17 | Quantum Biopharma Ltd | QNTM | 1.66% |
| 18 | Optimi Health Corp | OPTH | 1.18% |
| 19 | Pasithea Therapeutics Corp | KTTA | 1.09% |
| 20 | Silo Pharma Inc | SILO | 1.06% |
| 21 | Psyence Biomedical Ltd | PBM | 0.84% |
| 22 | Incannex Healthcare Inc | IXHL | 0.52% |
| 23 | Numinus Wellness Inc | NUMIF | 0.47% |
| 24 | IGC Pharma Inc | IGC | 0.41% |
| 25 | Vistagen Therapeutics Inc | VTGN | 0.22% |
| | Cash and other net assets | | 4.07% |

The largest 25 of 27 positions are shown. All of them: https://etfiq.com/funds/psil/holdings/psil-holdings.csv (CSV) or https://etfiq.com/data/books/psil.json (JSON).

Fund page: https://etfiq.com/funds/psil

Cite: ETFIQ, Holdings of PSIL, data as of Jun 30, 2026. https://etfiq.com/funds/psil/holdings/